聯創光電(600363.SH):聯創致光擬與賽戈瑪科技設立合資公司、將背光源非品牌業務與市場渠道優勢合作方進行重組
格隆匯11月22日丨聯創光電(600363.SH)公佈,公司控股子公司江西聯創致光科技有限公司(簡稱:“聯創致光”)為進一步加快資產優化,重點聚焦工控、車載、車載娛樂VR及品牌業務,將背光源板塊手機業務中的非品牌業務相關資產整體剝離出去,與深圳市賽戈瑪科技有限公司(簡稱:“賽戈瑪科技”)共同投資設立江西致瑪科技有限公司(簡稱:合資公司),主要從事電子元器件製造、電子專用材料銷售、電子元器件批發等業務,註冊資本為人民幣9900萬元,其中聯創致光以實物出資人民幣4500萬元,持股45.45%;賽戈瑪科技以現金出資人民幣5400萬元,持股54.55%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.